Latest updates in treatment for the field of HER2-positive breast cancer

Using combined oral contraceptives may decrease risk of Ovarian, Endometrial and Colorectal cancer

Isatuximab + Kd in RRMM: Depth of Response Results From the IKEMA Trial

Study shows that there is slower cancer drug approval in Europe

Cancer patient symptom and physical function reporting by caregivers used as predictors of adverse clinical outcomes

War in Ukraine: Global cancer aid to support refugees

War in Ukraine: The International Brain Tumour Alliance's response to aiding refugees during the crisis

Ibrutinib plus venetoclax for 1-L treatment of CLL and small lymphocytic lymphoma shows a clinically meaningful PFS

Rucaparib effective as maintenance therapy following first-line platinum-based chemo in ovarian cancer

RAGNAR study evidences efficacy and safety of erdafitinib in patients with advanced FGFR+ malignancies

ASCO and WHO to collaborate on quality indicators for cancer facilities

Lack of access to new cancer medicines in LMICs